The Readout Loud
STAT
Add to My Podcasts
Episodes
About
Reviews
Promote
Episode 35: Biotech's October slump, the precise cost of precision, and breaking postpartum silence
26 minutes
Posted Nov 1, 2018 at 10:05 pm.
0:00
26:12
Add to My Queue
Download
MP3
Share
episode
Share at current time
Show notes
Why are biotech stocks in the dumps? Is the latest in cancer care overhyped? And what does "folie à deux" mean?
Previous
Episode 34: Pharma at the ballot box, the latest Alzheimer's argument, and a rare disease dilemma
Next
Episode 36: What the midterms mean, a golden age on hold, and the $4 million drug
← See all 424 episodes of The Readout Loud
